ClinicalTrials.gov
public full text
Public Domain
Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media
The purpose of this study was to determine the pharmacokinetics (PK), safety and clinical response following a single dose of either 30 mg/kg IR (Immediate Release) or 60 mg/kg ER (Extended Release) formulation in pediatric subjects 6 months to 6 years of age inclusive.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparison of Effect of Dexmedetomidine and Midazolam on Emergence Agitation#863836
- A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine#980673
- Study to Evaluate Different Extended Release (ER)-Formulations and Multiple Ascending Dosing of AZD3241#981227
- Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso#1139686
- Xylitol Syrup for the Prevention of Acute Otitis Media in Otitis-prone Children#208479
Record · ID 897581
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive